This 2019 randomized controlled trial evaluated the efficacy of combining intensive behavioral therapy (IBT) with liraglutide 3.0 mg, with or without a 12-week meal replacement diet, in 150 adults with obesity over 52 weeks. Participants were assigned to one of three groups: IBT alone, IBT plus liraglutide, or IBT plus
